Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $2.37 is 39.41% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 2.58||$ 36.25|
|Low:||$ 2.37||$ 1.70|
Company Description (as filed with the SEC)
Altimmune, Inc. is a clinical stage immunotherapeutics company focused on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. Our product candidates are focused in two key areas for which we have unique proprietary approaches; i) our synthetic peptide technology for cancer and infectious disease, and ii) intranasal vaccines for infectious disease. Using these technologies, we have generated preclinical and clinical product candidates that potentially represent an entirely new approach to harnessing the immune system. In addition, we are seeking to acquire or in-license product candidates in immunotherapeutic indications that are either synergistic or complementary to our capabilities to expand our pipeline. HepTcell HepTcell is an immunotherapeutic product candidate for patients chronically infected with the hepatitis B virus ("HBV"). ... More ...
Nasdaq Official Price
Jun. 18, 2019
Jun. 17, 2019